P271 Single and multiples doses of the inhaled ENaC inhibitor BI 443651 are well tolerated in healthy males
Gordat, M., Singh, D., Brand, T., Endriss, V., Risse, F., Iacono, P.
Published in Journal of cystic fibrosis (01.06.2019)
Published in Journal of cystic fibrosis (01.06.2019)
Get full text
Journal Article
P272 The inhaled ENaC inhibitor BI 443651 does not affect response to methacholine but induces post-inhalation airway obstruction and cough in mild asthmatics
Khan, N., Dean, J., Singh, D., Gupta, A., Paterson, J., Endriss, V., Hobson, D., Iacono, P.
Published in Journal of cystic fibrosis (01.06.2019)
Published in Journal of cystic fibrosis (01.06.2019)
Get full text
Journal Article
WS06-6 The inhaled epithelial sodium channel (ENaC) inhibitor BI 443651 is safe and well tolerated in adult patients with cystic fibrosis
Elborn, S., Singh, D., Fischer, R., Kornmann, O., Schwarz, C., Mall, M., Horsley, A., Gordat, M., Endriss, V., Risse, F., Iacono, P.
Published in Journal of cystic fibrosis (01.06.2019)
Published in Journal of cystic fibrosis (01.06.2019)
Get full text
Journal Article
Sequential analysis of circulating tumor cells on genome and protein level: potential regulation of the invasion marker CapG by PIK3CA
Neumann, M, Decker, Y, Franken, A, Schömer, S, Schneck, H, Fehm, T, Weichert, W, Endriss, V, Neubauer, H, Niederacher, D
Published in Senologie - Zeitschrift für Mammadiagnostik und -therapie (26.04.2016)
Published in Senologie - Zeitschrift für Mammadiagnostik und -therapie (26.04.2016)
Get full text
Conference Proceeding